Pharmaceutical Industry Packaging Serialization Lagging as DSCSA Enforcement Deadline Looms

Press Release from GS1 US

LAWRENCEVILLE, N.J., Oct. 18, 2018 /PRNewswire/ -- Nearly 80 percent of pharmaceutical product packages still do not have a readable barcode with all four required data elements pursuant to the Drug Supply Chain Security Act (DSCSA)– despite the looming November 27, 2018 enforcement deadline – according to a barcode assessment study conducted by GS1 US®, in collaboration with AmerisourceBergen, Cardinal Health, and McKesson Pharmaceutical (McKesson).

The three pharmaceutical wholesalers, representing approximately 90 percent of pharmaceutical distribution in the U.S., examined package and homogenous case level barcodes in their distribution facilities in May 2018 to obtain a snapshot of industry's progress implementing DSCSA serialization requirements. When AmerisourceBergen and McKesson scanned 100 percent of on-hand package (lowest saleable unit) barcodes in their distribution centers, they found that only 20.7 percent (compared with 6.6 percent in 2017) of packages carried a readable 2D data matrix barcode with all four required data elements, including NDC (represented by Global Trade Item Number® (GTIN®)), serial number, lot number, and expiration date.

AmerisourceBergen assessed 5,009 packages of specialty medications and McKesson analyzed prescription pharmaceuticals, scanning 16,200 packages. Cardinal Health evaluated homogeneous case-level barcodes on pharmaceutical products, scanning 15,708 barcodes on 6,481 cases, and found just 15.1 percent of homogeneous cases were marked with the 2D barcode and four data elements.

Additional issues identified in the assessment include poor barcode placement, a lack of alignment when UPC-A and 2D barcodes are both required on the same package, serialization adherence, improper coding, and inconsistent expiration date formats.

"The industry has made only marginal progress in the past year toward implementing DSCSA serialization, and U.S. FDA enforcement is around the corner," said Siobhan O'Bara, SVP industry engagement and services, GS1 US. "Just over one month from now, failure to meet these critical requirements could begin to negatively impact companies' reputations and bottom lines, so time is of the essence."

AmerisourceBergen, Cardinal Health, and McKesson recommend suppliers refer to and implement GS1 Standards for barcode guidance with size, placement, encoding, and more, to improve barcode quality. All three wholesalers offer implementation assistance, including sample barcode testing, educational sessions, and individualized support. Suppliers should also pay particular attention to barcode placement on cases and packages to avoid readability issues, and use the DSCSA education and implementation resources available from GS1 US. Finally, they urge suppliers to accelerate the implementation of serialization and address any issues now.

"Compliance is critical," said Ms. O'Bara, "but it is important to understand that the whole point of serialization is ultimately to effect industry-wide improvements in traceability, efficiency and accuracy – and most of all, patient safety – goals we can all get behind."

Details of the barcode assessment methodology and findings, as well as recommendations and resources to support implementation, are published in a new GS1 US report, "2018 Update: Implementation of DSCSA Serialization Requirements." For more information about GS1 US, visit www.gs1us.org.

About GS1 Healthcare US
GS1 Healthcare US® is an industry group that focuses on driving the adoption and implementation of GS1 Standards in the healthcare industry in the United States to improve patient safety and supply chain efficiency. GS1 Healthcare US brings together members from all segments of the healthcare industry to address the supply chain issues that most impact healthcare in the United States. Facilitated by GS1 US, GS1 Healthcare US is one of more than 30 local GS1 Healthcare user groups around the world that support the adoption and implementation of global standards developed by GS1®. For more information, visit www.gs1us.org/healthcare.

About GS1 US
GS1 US®, a member of GS1® global, is a not-for-profit information standards organization that facilitates industry collaboration to help improve supply chain visibility and efficiency through the use of GS1 Standards, the most widely-used supply chain standards system in the world. Nearly 300,000 businesses in 25 industries rely on GS1 US for trading partner collaboration that optimizes their supply chains, drives cost performance and revenue growth while also enabling regulatory compliance. They achieve these benefits through solutions based on GS1 global unique numbering and identification systems, barcodes, Electronic Product Code(EPC®)-based RFID, data synchronization, and electronic information exchange. GS1 US also manages the United Nations Standard Products and Services Code® (UNSPSC®). www.gs1us.org.

Cision View original content:http://www.prnewswire.com/news-releases/pharmaceutical-industry-packaging-serialization-lagging-as-dscsa-enforcement-deadline-looms-300733070.html

SOURCE GS1 US

Companies Mentioned in this Press Release:
Business Categories Mentioned in this Press Release: